Live Breaking News & Updates on Urolithina Urolithin

Stay updated with breaking news from Urolithina urolithin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Redirecting to Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle Function and Life Expectancy in Mice With Muscle Dystrophy


April 9, 2021 healthcare
Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle Function and Life Expectancy in Mice With Muscle Dystrophy
Progression of Duchenne Muscle Dystrophy (DMD) can be delayed in mice by supplementing their diets with Urolithin A, according to new results reported today. The findings, published in Science Translational Medicine, raise hopes that new treatment options could one-day be developed for DMD, an uncurable genetic condition characterized by progressive muscle degeneration. About 1 in 3,500 boys are born with DMD, which usually develops in childhood and significantly reduces life expectancy.
The new research carried out at the laboratory of Professor Johan Auwerx, MD, PhD at the Swiss Federal Institute of Technology EPFL and the University of Lausanne in collaboration with scientists at the Swiss life science company Amazentis, highlights the important role that defective mitochondria can play in ....

Peiling Luan , Chris Rinsch , Johan Auwerx , Urolithina Urolithin , Davide Damico , Swiss Federal Institute Of Technology , University Of Lausanne , Administration Of Urolithin , Duchenne Muscle Dystrophy , Science Translational Medicine , Professor Johan Auwerx , Swiss Federal Institute , Muscle Dystrophy , Davided Amico , Project Leader , Nature Medicine , Nature Metabolism , டேவிட் டாமிகோ , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , அறிவியல் மொழிபெயர்ப்பு மருந்து , சுவிஸ் கூட்டாட்சியின் நிறுவனம் , தசை டிஸ்ட்ரோபி , ப்ராஜெக்ட் தலைவர் , இயற்கை மருந்து , இயற்கை வளர்சிதை மாற்றம் ,

Study shows Urolithin A as a potent enhancer of muscle function in mice with muscular dystrophy


Study shows Urolithin A as a potent enhancer of muscle function in mice with muscular dystrophy
Apr 9 2021
Progression of Duchenne Muscle Dystrophy (DMD) can be delayed in mice by supplementing their diets with Urolithin A, according to new results reported today. The findings, published in
Science Translational Medicine, raise hopes that new treatment options could one-day be developed for DMD, an uncurable genetic condition characterized by progressive muscle degeneration. About 1 in 3,500 boys are born with DMD, which usually develops in childhood and significantly reduces life expectancy.
The new research carried out at the laboratory of Professor Johan Auwerx, MD, PhD at the Swiss Federal Institute of Technology EPFL and the University of Lausanne in collaboration with scientists at the Swiss life science company Amazentis, highlights the important role that defective mitochondria can play in DMD. The powerhouses of cells, mitochondria produce the energy nece ....

Peiling Luan , Chris Rinsch , Johan Auwerx , Urolithina Urolithin , Davide Damico , Swiss Federal Institute Of Technology , University Of Lausanne , Administration Of Urolithin , Duchenne Muscle Dystrophy , Science Translational Medicine , Professor Johan Auwerx , Swiss Federal Institute , Muscle Dystrophy , Davided Amico , Project Leader , Nature Medicine , Nature Metabolism , டேவிட் டாமிகோ , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , அறிவியல் மொழிபெயர்ப்பு மருந்து , சுவிஸ் கூட்டாட்சியின் நிறுவனம் , தசை டிஸ்ட்ரோபி , ப்ராஜெக்ட் தலைவர் , இயற்கை மருந்து , இயற்கை வளர்சிதை மாற்றம் ,

Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle Function and Life Expectancy in Mice With Muscle Dystrophy


Amazentis
Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle Function and Life Expectancy in Mice With Muscle Dystrophy
Thursday, April 8, 2021 12:42PM IST (7:12AM GMT)
Results from Swiss scientists showing mitophagy inducer Urolithin A can restore muscle cell activity in models of Duchenne Muscular Dystrophy publishedin Science Translational Medicine
 
Lausanne, Switzerland:
 
Progression of Duchenne Muscle Dystrophy (DMD) can be delayed in mice by supplementing their diets with Urolithin A, according to new results reported today. The findings, published in
Science Translational Medicine, raise hopes that new treatment options could one-day be developed for DMD, an uncurable genetic condition characterized by progressive muscle degeneration. About 1 in 3,500 boys are born with DMD, which usually develops in childhood and significantly reduces life expectancy. ....

Federico Luna , Peiling Luan , Chris Rinsch , Johan Auwerx , Urolithina Urolithin , Davide Damico , Swiss Federal Institute Of Technology , University Of Lausanne , Administration Of Urolithin , Duchenne Muscle Dystrophy , Science Translational Medicine , Professor Johan Auwerx , Swiss Federal Institute , Muscle Dystrophy , Davided Amico , Project Leader , Nature Medicine , Nature Metabolism , Media Contact , Marketing Officer Amazentis , ஃபெடரீகொ லூனா , டேவிட் டாமிகோ , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , அறிவியல் மொழிபெயர்ப்பு மருந்து , சுவிஸ் கூட்டாட்சியின் நிறுவனம் , தசை டிஸ்ட்ரோபி ,

Amazentis: Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle Function and Life Expectancy in Mice With Muscle Dystrophy


Amazentis: Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle Function and Life Expectancy in Mice With Muscle Dystrophy
in Science Translational Medicine
Progression of Duchenne Muscle Dystrophy (DMD) can be delayed in mice by supplementing their diets with Urolithin A, according to new results reported today. The findings, published in
Science Translational Medicine, raise hopes that new treatment options could one-day be developed for DMD, an uncurable genetic condition characterized by progressive muscle degeneration. About 1 in 3,500 boys are born with DMD, which usually develops in childhood and significantly reduces life expectancy.
The new research carried out at the laboratory of Professor Johan Auwerx, MD, PhD at the Swiss Federal Institute of Technology EPFL and the University of Lausanne in collaboration with scientists at the Swiss life science company Amazentis, highlights the important role that defective mitochondria can play ....

Kostenloser Wertpapierhandel , Federico Luna , Peiling Luan , Chris Rinsch , Johan Auwerx , Urolithina Urolithin , Davide Damico , Swiss Federal Institute Of Technology , University Of Lausanne , Administration Of Urolithin , Duchenne Muscular Dystrophy , Science Translational , Duchenne Muscle Dystrophy , Science Translational Medicine , Professor Johan Auwerx , Swiss Federal Institute , Muscle Dystrophy , Davided Amico , Project Leader , Nature Medicine , Nature Metabolism , Marketing Officer Amazentis , ஃபெடரீகொ லூனா , டேவிட் டாமிகோ , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , அறிவியல் மொழிபெயர்ப்பு ,

Urolithin A shows effective against muscular dystrophy


Credit: © Amazentis / EPFL Auwerx Lab
Progression of Duchenne Muscle Dystrophy (DMD) can be delayed in mice by supplementing their diets with Urolithin A, according to new results reported today. The findings, published in
Science Translational Medicine, raise hopes that new treatment options could one-day be developed for DMD, an uncurable genetic condition characterized by progressive muscle degeneration. About 1 in 3,500 boys are born with DMD, which usually develops in childhood and significantly reduces life expectancy.
The new research carried out at the laboratory of Professor Johan Auwerx, MD, PhD at the Swiss Federal Institute of Technology EPFL and the University of Lausanne in collaboration with scientists at the Swiss life science company Amazentis, highlights the important role that defective mitochondria can play in DMD. The powerhouses of cells, mitochondria produce the energy necessary for normal muscle function. But muscle cells taken from both huma ....

Peiling Luan , Chris Rinsch , Johan Auwerx , Urolithina Urolithin , Davide Damico , Swiss Federal Institute Of Technology , University Of Lausanne , Administration Of Urolithin , Duchenne Muscle Dystrophy , Science Translational Medicine , Professor Johan Auwerx , Swiss Federal Institute , Muscle Dystrophy , Davided Amico , Project Leader , Nature Medicine , Nature Metabolism , டேவிட் டாமிகோ , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , அறிவியல் மொழிபெயர்ப்பு மருந்து , சுவிஸ் கூட்டாட்சியின் நிறுவனம் , தசை டிஸ்ட்ரோபி , ப்ராஜெக்ட் தலைவர் , இயற்கை மருந்து , இயற்கை வளர்சிதை மாற்றம் ,